- Amended Current report filing (8-K/A)
May 28 2010 - 2:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 5, 2010
Impax Laboratories, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-34263
|
|
65-0403311
|
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
30831 Huntwood Avenue, Hayward, CA
|
|
94544
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(510) 476-2000
|
Not Applicable
|
(Former name or former address if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 5.02
|
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
|
On May 26, 2010, the Companys board of directors appointed Allen Chao, Ph.D., who was first elected to serve as a
director on April 5, 2010, to serve on the audit committee of the board.
At the Annual Meeting of Stockholders of the Company held on May 25, 2010, the stockholders approved the amendment
and restatement of the Companys Amended and Restated 2002 Equity Incentive Plan to increase the aggregate number of
shares of common stock authorized for issuance under the plan by 2,000,000 shares. Such increase had been approved by
the board of directors in February 2010, subject to stockholder approval. A summary of the Amended and Restated Plan
is included in the Companys proxy statement filed with the Securities and Exchange Commission on April 14, 2010.
Item 5.07
|
|
Submission of Matters to a Vote of Security Holders.
|
At the May 25 Annual Meeting, the Companys stockholders (i) elected Leslie Z. Benet, Ph.D., Robert L. Burr, Allen
Chao, Ph.D., Nigel Ten Fleming, Ph.D., Larry Hsu, Ph.D., Michael Markbreiter and Peter R. Terreri to the board of
directors of the Company, each for a term of one year and until his successor is elected and qualified or until the
directors earlier death, resignation or removal; (ii) approved the increase in authorized shares under the 2002 equity
incentive plan as described above; and (iii) ratified the appointment of Grant Thornton LLP as the Companys
independent registered public accounting firm for the fiscal year ending December 31, 2010.
The results of the stockholder vote for each proposal were as follows:
|
(1)
|
|
Election of Directors:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominee
|
|
Votes For
|
|
Withheld Authority
|
|
Broker Non-Votes
|
Leslie Z. Benet, Ph.D.
|
|
|
40,626,843
|
|
|
|
4,511,447
|
|
|
|
9,331,391
|
|
Robert L. Burr
|
|
|
40,646,094
|
|
|
|
4,492,196
|
|
|
|
9,331,391
|
|
Allen Chao, Ph.D.
|
|
|
44,730,248
|
|
|
|
408,042
|
|
|
|
9,331,391
|
|
Nigel Ten Fleming, Ph.D.
|
|
|
39,811,672
|
|
|
|
5,326,618
|
|
|
|
9,331,391
|
|
Larry Hsu, Ph.D.
|
|
|
43,974,135
|
|
|
|
1,164,155
|
|
|
|
9,331,391
|
|
Michael Markbreiter
|
|
|
43,908,386
|
|
|
|
1,229,904
|
|
|
|
9,331,391
|
|
Peter R. Terreri
|
|
|
44,744,380
|
|
|
|
393,910
|
|
|
|
9,331,391
|
|
|
|
(2)
|
|
Approval of the Increase in Shares under the 2002 Plan:
|
|
|
|
|
|
Votes For
|
|
|
34,242,303
|
|
Votes Against
|
|
|
10,772,476
|
|
Abstentions
|
|
|
134,511
|
|
Broker Non-Votes
|
|
|
9,320,391
|
|
|
(3)
|
|
Ratification of the Appointment of Grant Thornton LLP as the Companys Independent Registered
Public Accounting Firm:
|
|
|
|
|
|
Votes For
|
|
|
54,315,934
|
|
Votes Against
|
|
|
125,542
|
|
Abstentions
|
|
|
28,205
|
|
Broker Non-Votes
|
|
|
None
|
|
1
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 28, 2010
IMPAX LABORATORIES, INC
.
By:
/s/ Arthur A. Koch, Jr.
Name: Arthur A. Koch, Jr.
Title: Senior Vice President, Finance, and
Chief Financial Officer
2
3
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From Jul 2024 to Jul 2024
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From Jul 2023 to Jul 2024